e8vk

0000893220-08-001630.txt : 20080520 0000893220-08-001630.hdr.sgml : 20080520 20080520140221 ACCESSION NUMBER: 0000893220-08-001630 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20080520 ITEM INFORMATION: Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20080520 DATE AS OF CHANGE: 20080520 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ERESEARCHTECHNOLOGY INC /DE/ CENTRAL INDEX KEY: 0001026650 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-TESTING LABORATORIES [8734] IRS NUMBER: 223264604 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-29100 FILM NUMBER: 08848063 BUSINESS ADDRESS: STREET 1: 30 SOUTH 17TH STREET CITY: PHILADELPHIA STATE: PA ZIP: 19103 BUSINESS PHONE: 2159720420 MAIL ADDRESS: STREET 1: 30 SOUTH 17TH STREET CITY: PHILADELPHIA STATE: PA ZIP: 19102 FORMER COMPANY: FORMER CONFORMED NAME: PREMIER RESEARCH WORLDWIDE LTD DATE OF NAME CHANGE: 19961107 8-K 1 w58978e8vk.htm FORM 8-K ERESEARCH TECHNOLOGY, INC. e8vk

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report: May 20, 2008
(Date of earliest event reported)

eResearchTechnology, Inc.

(Exact name of Registrant as specified in its charter)


Delaware	0-29100	22-3264604

(State or other jurisdiction of incorporation)	(Commission File Number)	(I.R.S. Employer Identification No.)


30 South 17^th Street, Philadelphia, PA		19103

(Address of principal executive offices)		(Zip Code)

215-972-0420

(Registrant’s telephone number, including area code)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

o		Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o		Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o		Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o		Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

ITEM 5.02 DEPARTURE OF DIRECTORS OR CERTAIN OFFICERS; ELECTION OF DIRECTORS; APPOINTMENT OF CERTAIN OFFICERS; COMPENSATORY ARRANGEMENTS OF CERTAIN OFFICERS.

On May 20, 2008, eResearchTechnology, Inc. (“eRT”) issued a press release announcing that Richard Baron has informed eRT that he will resign as Executive Vice President and Chief Financial Officer effective June 17, 2008 and will become chief financial officer of Avid Radiopharmaceuticals, Inc. a privately-held company based in Philadelphia. Effective on June 17, 2008, Steven M. Eisenstein, who is 44 and has been eRT’s Controller for seven years and a Vice President since May 2005, will become eRT’s interim chief financial officer and principal financial and accounting officer, while Michael J. McKelvey, eRT’s President and Chief Executive Officer, will assume the non-financial responsibilities currently performed by Mr. Baron, including investor relations and certain operating functions. Mr. Baron will be assisting in the transition and a search for a permanent chief financial officer will commence. A copy of the press release is filed herewith as Exhibit 99.1 and incorporated by reference herein.

ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS

Exhibit 99.1 Press release dated May 20, 2008 of eResearchTechnology, Inc.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.


	eResearchTechnology, Inc. (Registrant)
Date: May 20, 2008	By:	/s/ Michael J. McKelvey
		Michael J. McKelvey,
		President and Chief Executive Officer

EXHIBIT INDEX


Exhibit No.		Exhibit
	99.1	Press Release dated May 20, 2008 of eResearchTechnology, Inc.

EX-99.1 2 w58978exv99w1.htm PRESS RELEASE exv99w1

Exhibit 99.1

eResearchTechnology Announces Resignation of its CFO

PHILADELPHIA, May 20/PRNewswire-FirstCall/ — eResearchTechnology, Inc. (eRT), (Nasdaq: ERES - News), a leading provider of centralized ECG and eClinical technology, ePRO and other services to the pharmaceutical, biotechnology, medical device and related industries, announced today that Richard Baron has informed the company that he will resign as Executive Vice President and Chief Financial Officer effective June 17, 2008 and will become Chief Financial Officer of Avid Radiopharmaceuticals, Inc., a privately-held company based in Philadelphia. Effective on June 17, 2008, Steven M. Eisenstein, eRT’s Vice President and Controller, who has been Controller of eRT for seven years, will become the interim Chief Financial Officer and principal financial and accounting officer, while Michael J. McKelvey, eRT’s President and Chief Executive Officer, will assume the non-financial responsibilities currently performed by Mr. Baron, including investor relations and certain operating functions. Mr. Baron will be assisting in the transition and a search for a permanent chief financial officer will commence.

“Rick has made very significant contributions to the company’s overall success through his leadership of finance and other areas of the company,” said Dr. McKelvey. “The company is a better one having been associated with Rick, and we will miss him. While it is never easy to part company with a valued colleague, we are fortunate that Rick has developed a strong financial team under his direction to be able to transition to a new CFO. We wish him tremendous success in his new position.”

“It has been a privilege to work at eRT and I am very proud of the highly capable team that we have created.” said Mr. Baron. “I am looking forward to the challenges and rewards of working with a clinical stage company and I am fully committed to assisting eRT’s senior management and Board of Directors to ensure a smooth transition.”

Based in Philadelphia, PA, eResearchTechnology, Inc. (http://www.eRT.com) is a provider of technology and services to the pharmaceutical, biotechnology and medical device industries on a global basis. The Company is a market leader in providing centralized core-diagnostic electrocardiographic (ECG) technology and services to evaluate cardiac safety in clinical development. The Company is also a leader in providing technology and services to streamline the clinical trials process by enabling its customers to automate the collection, analysis, and distribution of clinical data in all phases of clinical development.

Statements included in this release may constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements, including, but not limited to, 2008 financial guidance, involve a number of risks and uncertainties such as the Company’s ability to obtain new contracts and accurately estimate net revenues due to uncertain regulatory guidance, variability in size, scope and duration of projects, and internal issues at the sponsoring client, integration of acquisitions, competitive factors, technological development, and market demand. As a result, actual results may differ materially from any financial outlooks stated herein. Further information on potential factors that could affect the Company’s financial results

can be found in the Company’s Reports on Form 10-K and 10-Q filed with the Securities and Exchange Commission. The Company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events, or otherwise.


		Contact:
		Richard Baron		Robert East
		eResearchTechnology, Inc.		Westwicke Partners, LLC
		215-282-5566		410-321-9652